Metabolomics and Precision Medicine in Resistant Hypertension: Pathophysiological Insights, Biomarker Discovery, and Translational Strategies
This structured narrative review synthesizes RH‐specific metabolomic evidence and distinguishes it from findings extrapolated from broader hypertension populations, and discusses methodological challenges, replication gaps, pharmacometabolomic confounding, and validation standards required for clinical implementation.